Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2005 Oct 29;331(7523):1023.
doi: 10.1136/bmj.331.7523.1023.

ASCOT: a tale of two treatment regimens: is ASCOT all it's cracked up to be?

James A Cave
Comment

ASCOT: a tale of two treatment regimens: is ASCOT all it's cracked up to be?

James A Cave. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

  • ASCOT: a tale of two treatment regimens.
    McDougall C, Brady AJ, Petrie JR. McDougall C, et al. BMJ. 2005 Oct 15;331(7521):859-60. doi: 10.1136/bmj.331.7521.859. BMJ. 2005. PMID: 16223801 Free PMC article. No abstract available.

References

    1. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers GD, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366: 895-906. - PubMed
    1. McDougall C, Brady AJB, Petrie JR. ASCOT: a tale of two treatment regimens. BMJ 2005;331: 859-60. (15 October.) - PMC - PubMed
    1. Poulter NR, Wedel H, Dahlof B, Sever PS, Beevers GD, Caulfield M, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA). Lancet 2005;366: 907-13 - PubMed
    1. Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Cavazzini C, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies; a meta-analysis of randomised controlled trials. Lancet 2000;356: 1949-54. - PubMed

MeSH terms

Substances